Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 18, 2026 | BlueCross BlueShield of Tennessee | Epoetin Alfa Products(Epogen, Procrit, Retacrit) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Epcoritamab-bysp (Epkinly) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Vedolizumab (Entyvio) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Fam-trastuzumab Deruxtecan-nxki (Enhertu) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Enfortumab Vedotin-ejfv (Padcev) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Telisotuzumab vedotin-tllv (Emrelis) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Emapalumab-lzsg (Gamifant) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Tagraxofusp-erzs (Elzonris) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Elranatamab-bcmm(Elrexfio) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Elotuzumab (Empliciti) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Elosulfase Alfa (Vimizim) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Elivaldogene Autotemcel (Skysona) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Taliglucerase Alfa (Elelyso) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Responsive Neurostimulation for the Treatment of Refractory Focal Epilepsy | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Functional Neuromuscular Electrical Stimulation | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Idursulfase (Elaprase) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Elapegademase-lvir(Revcovi) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Mirvetuximab Soravtansine-gynx (Elahere) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Eflapegrastim-xnst (Rolvedon) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Efgartigimod Alfa-fcab (Vyvgart); Efgartigimod Alfa-fcab and Hyaluronidase-qvfc (VyvgartHytrulo) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Efbemalenograstim alfa-vuxw (Ryzneuta) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Edaravone (Radicava) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Ecallantide (Kalbitor) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Durvalumab (Imfinzi) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Hyaluronic Acid Derivatives: Durolane, Euflexxa, Gel-One, GelSyn-3, GenVisc 850, Hyalgan, Hymovis, Hymovis One, Monovisc, Orthovisc, Supartz FX, Synojoynt, Synvisc, & Synvisc-One, Triluron, TriVisc, VISCO-3 | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Dostarlimab-gxly (Jemperli) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Digital Health Technologies: Diagnostic Applications | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Dexamethasone Implant (Ozurdex) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Denosumab Products: (Xgeva); Denosumab-kyqq (Aukelso); Denosumab-nxxp (Bilprevda); Denosumab-bnht (Bomyntra); Denosumab-desu (Jubereq); Denosumab-bmwo (Osenvelt); Denosumab-mobz (Oziltus); Denosumab-bbdz (Wyost); Denosumab-dssb (Xbryk), Denosumab-qbde (Xtrenbo) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Denosumab Products: (Prolia); Denosumab-nxxp (Bildyos); Denosumab-mobz (Boncresa);Denosumab-kyqq (Bosaya); Denosumab-bnht (Conexxence); Denosumab-qbde (Enoby); Denosumab-bbdz (Jubbonti); Denosumab-dssb (Ospomyv); Denosumab-desu (Osvyrti); Denosumab-bmwo (Stoboclo | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Denileukin diftitox-cxdl (Lymphir) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Delandistrogene moxeparvovec-rokl (Elevidys) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Degarelix (Firmagon) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Datopotamab Deruxtecan-dlnk (Datroway) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Daratumumab and hyaluronidase-fihj (Darzalex Faspro) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Daratumumab (Darzalex) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Naxitamab-gqgk (Danyelza) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Daily Hemodialysis in the Home | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Daunorubicin and Cytarabine, Liposome (Vyxeos) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | SCIG (Immune Globulin SQ): Hizentra, Hyqvia, Cuvitru, Cutaquig, Xembify | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Crovalimab-akkz (Piasky) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Cosibelimab-ipdl (Unloxcyt) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Trilaciclib (Cosela) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Collagenase Clostridium Histolyticum (Xiaflex) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Circulating Tumor DNA (Liquid Biopsy) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Cipaglucosidase Alfa-atga (Pombiliti) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Cetuximab (Erbitux) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Cervical Traction Devices for Home Use | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Cemiplimab-rwlc (Libtayo) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Exagamglogene Autotemcel (Casgevy) | Criteria changed |